An assessment of chemotherapy-induced nausea and vomiting direct costs in three EU countries


BACKGROUND chemotherapy-induced nausea and vomiting (CINV) has been commonly reported as one of the most distressing adverse effects among treated patients with cancer. Inadequately treated, CINV can lead to increased resource utilization and severely impair patients' daily functioning and quality of life. Direct costs include acquisition cost of antiemetic… (More)
DOI: 10.7573/dic.212285

7 Figures and Tables


  • Presentations referencing similar topics